Everyday Care: Managing Symptoms and Staying Safe
At a Glance
Children with Fukuyama congenital muscular dystrophy need individualized team care to monitor breathing and swallowing, manage seizures and mobility, and respond quickly to warning signs such as under-breathing, choking, sudden weakness, or prolonged seizures.
Because Fukuyama Congenital Muscular Dystrophy (FCMD) affects many systems of the body, there is no single “cure” or pill. Instead, the standard of care is multidisciplinary management—a team approach where specialists work together to prevent complications and keep your child comfortable and engaged in life [1].
Respiratory Support and Monitoring
Breathing muscles can weaken over time, often becoming a primary focus as children grow [2]. Because cognitive impairment can sometimes mask the early signs of breathing trouble—like morning headaches or insomnia—regular testing is essential [2]. Early signs of poor breathing (hypoventilation) also include unusual sleepiness, difficulty waking, weak cough, vomiting, or behavior changes.
- Noninvasive Ventilation (NIV): This typically involves a machine (like a BiPAP) and a mask worn during sleep to help the lungs exchange oxygen and carbon dioxide. In one study of FCMD patients, many began using this support around age 12 [2]. However, respiratory assessment is individualized based on symptoms, not just age.
- Cough Assistance: When cough muscles are weak, mucus can get trapped in the lungs, leading to infections. A mechanical insufflation-exsufflation (cough-assist) machine helps clear these secretions [2]. This is often used daily and increased during colds to prevent pneumonia [1]. Work with your team to create a sick-day plan.
- Lung Volume Recruitment: This technique (sometimes called “air stacking”) helps keep the chest wall flexible and helps the child take deeper breaths than they could on their own [3][4].
Nutrition and Swallowing
Many children with FCMD experience dysphagia, or difficulty swallowing [5]. This can lead to aspiration, where food or liquid “goes down the wrong pipe” and enters the lungs.
- Signs of Trouble: These include coughing or choking during meals, a “wet” sounding voice, or frequent chest infections [6].
- Management: A speech-language pathologist and dietitian can help. Texture modifications (like thickening liquids) should follow an individualized clinical and instrumental swallow assessment (such as VFSS or FEES), as thickened liquids can create hydration problems. If swallowing becomes unsafe or if the child cannot eat enough to grow, a feeding tube (gastrostomy) may be recommended to provide nutrition safely [7]. Note that a feeding tube does not eliminate aspiration of saliva or reflux.
Seizure Care and the “Mask of Weakness”
Seizures are common in FCMD and require ongoing vigilance, as they can emerge for the first time even in late adolescence [8].
- Subtle Seizures: As muscle weakness progresses, a child may not have the strength for a typical “shaking” seizure. Instead, seizures may look like staring spells, behavioral pauses, or brief moments of unresponsiveness [8].
- Medication: Antiseizure treatment is individualized. Most FCMD-related seizures can be managed with medication, but any changes should be neurologist-led. For instance, if your child is prescribed valproate, your doctor will monitor for risks such as liver injury (hepatotoxicity), pancreatitis, lowered platelet counts, hyperammonemia, and a rare kidney issue related to low carnitine levels [9]. Follow a clear seizure first-aid/rescue-medication plan, and watch for symptoms requiring urgent review like vomiting, marked lethargy, confusion, or jaundice.
Orthopedic and Physical Therapy
Maintaining mobility and comfort is a major goal of care. Physical therapy (PT) focuses on range of motion to prevent contractures (permanent tightening of the muscles and joints) and monitors hip alignment [10][11].
- Scoliosis: A curvature of the spine is very common as children grow. If the curve becomes severe, it can make sitting painful and interfere with breathing [12].
- Spinal Fusion: Surgery to straighten the spine is sometimes considered. Surgical decisions depend on curve progression, growth, seating, pain, pulmonary and cardiac status, bone health, and the risks of alternatives [13]. Because of the risks to the heart and lungs, this surgery requires specialized anesthesia and close monitoring after the operation [12][2].
URGENT: When to Seek Emergency Assessment
Work with your doctor to create a written ‘Emergency Respiratory Action Plan’ that includes baseline settings. It is normal for children with FCMD to have stable, long-term muscle weakness. However, certain symptoms during a viral infection or fever require urgent assessment.
Seek immediate care if your child experiences:
- Signs of Hypoventilation: Unusual sleepiness, morning headache, altered behavior, or weak cough.
- Acute Respiratory Distress: Blue or gray color around the lips, rapid breathing, or using “extra” muscles to breathe (Note: these can be late signs) [2]. Warning: Supplemental oxygen alone can mask or worsen CO2 retention and should not replace prescribed ventilatory support.
- Sudden Deterioration: Severe, sudden-onset weakness (much worse than their baseline) or “tea-colored” or dark urine during a fever. This requires urgent clinical assessment to check for dehydration, infection, or muscle breakdown [14].
- Status Epilepticus: A seizure that lasts more than 5 minutes or multiple seizures without waking up in between [8].
Common questions in this guide
What breathing symptoms are emergencies for a child with FCMD?
How are breathing problems monitored and treated in FCMD?
What should I do if my child has swallowing difficulty with FCMD?
Can seizures in FCMD happen without shaking?
How can FCMD care protect mobility and manage scoliosis?
What belongs in an emergency plan for a child with FCMD?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my child's current 'peak cough flow,' and at what point should we begin using a cough-assist machine at home?
- 2.Since respiratory issues can be masked, what objective tests (like sleep studies or CO2 monitoring) will we use to decide when to start nighttime ventilation?
- 3.Can you help us create a written 'Emergency Respiratory Action Plan' for use during common viral infections?
- 4.Has my child's swallowing been formally evaluated recently with a VFSS or FEES test, even if I haven't noticed obvious choking?
- 5.What are the specific signs of 'silent' seizures we should look for, and can we create a seizure first-aid plan?
- 6.If scoliosis surgery becomes necessary, how will the surgical team manage the specific risks of difficult extubation and heart function in a child with FCMD?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.
Kang PB, Morrison L, Iannaccone ST, et al.
Neurology 2015; (84(13)):1369-78 doi:10.1212/WNL.0000000000001416.
PMID: 25825463 - 2
Respiratory management of patients with Fukuyama congenital muscular dystrophy.
Sato T, Murakami T, Ishiguro K, et al.
Brain & development 2016; (38(3)):324-30.
PMID: 26363734 - 3
Respiratory Management of the Patient With Duchenne Muscular Dystrophy.
Sheehan DW, Birnkrant DJ, Benditt JO, et al.
Pediatrics 2018; (142(Suppl 2)):S62-S71 doi:10.1542/peds.2018-0333H.
PMID: 30275250 - 4
Cough Augmentation in Subjects With Duchenne Muscular Dystrophy: Comparison of Air Stacking via a Resuscitator Bag Versus Mechanical Ventilation.
Toussaint M, Pernet K, Steens M, et al.
Respiratory care 2016; (61(1)):61-7 doi:10.4187/respcare.04033.
PMID: 26443018 - 5
National registry of patients with Fukuyama congenital muscular dystrophy in Japan.
Ishigaki K, Ihara C, Nakamura H, et al.
Neuromuscular disorders : NMD 2018; (28(10)):885-893 doi:10.1016/j.nmd.2018.08.001.
PMID: 30220444 - 6
Laminin-α2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment.
Durbeej M
Current topics in membranes 2015; (76()):31-60.
PMID: 26610911 - 7
A case of Fukuyama-type congenital muscular dystrophy with acute carnitine deficiency triggered by fever, vomiting, and gastrointestinal bleeding.
Uchiyama SI, Korematsu S, Wasada R, et al.
Nutrition (Burbank, Los Angeles County, Calif.) 2023; (110()):112011 doi:10.1016/j.nut.2023.112011.
PMID: 36965241 - 8
Epilepsy in patients with advanced Fukuyama congenital muscular dystrophy.
Kuwayama R, Suzuki Y, Nishikawa M, et al.
Brain & development 2021; (43(1)):106-110 doi:10.1016/j.braindev.2020.06.017.
PMID: 32723526 - 9
Renal dysfunction is rare in Fukuyama congenital muscular dystrophy.
Ishigaki K, Kato I, Murakami T, et al.
Brain & development 2019; (41(1)):43-49 doi:10.1016/j.braindev.2018.07.012.
PMID: 30077507 - 10
The congenital muscular dystrophies.
Topaloğlu H, Poorshiri B
Annals of the Child Neurology Society 2024; (2(1)):27-39 doi:10.1002/cns3.20050.
PMID: 42563889 - 11
Evidence based position paper on Physical and Rehabilitation Medicine practice for people with muscular dystrophies.
Lazovic M, Nikolic D, Boyer FC, et al.
European journal of physical and rehabilitation medicine 2021; (57(6)):1036-1044 doi:10.23736/S1973-9087.21.07121-5.
PMID: 34823337 - 12
Spinal correction in patients with Fukuyama congenital muscular dystrophy.
Saito W, Namba T, Inoue G, et al.
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2017; (22(4)):658-664 doi:10.1016/j.jos.2017.02.005.
PMID: 28325699 - 13
Spinal fusion in a patient with Fukuyama congenital muscular dystrophy.
Hino K, Fukuda M, Morino T, et al.
Brain & development 2017; (39(7)):613-616 doi:10.1016/j.braindev.2017.02.003.
PMID: 28318781 - 14
Acute rhabdomyolysis following viral infection with coxsackie A4 in a 50-day-old infant with Fukuyama congenital muscular dystrophy.
Yamaguchi H, Taniguchi-Ikeda M, Nagase H, et al.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2020; (26(5)):516-519 doi:10.1016/j.jiac.2019.12.015.
PMID: 31983616
This page is for informational purposes only and does not constitute medical advice. Your child's neuromuscular, respiratory, and other specialists should tailor care, monitoring, and emergency plans to your child's needs.
Get notified when new evidence is published on Congenital muscular dystrophy, Fukuyama type.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.